Itamar Medical Ltd (ITMMF) 0.4270 $ITMMF
Micro Market Monitor: North American Sleep Apnea Devices
M2 - Thu Dec 18, 6:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/dnzfqg/micro_market) has announced the addition of the "Micro Market Monitor: North American Sleep Apnea Devices" report to their offering. The North American sleep apnea devices market is estimated to grow at a CAGR of 15.9% from 2014 to 2019. In 2013, the U.S. held the largest share in the North American sleep apnea devices market with 92.2%, followed by Canada. This market holds high growth potential in the future due to a number of forces favoring this market. These include the continuously growing base of sleep apnea patients, increasing awareness of sleep apnea and available diagnostic/therapeutic options, emerging popularity of oral appliances, and technological advancement. About 4% of men and 2% of women suffer from obstructive sleep apnea (OSA), globally. Due to rising obesity rates, the association of comorbidities such as drug-resistant hypertension, congestive heart failure, Type 2 diabetes, and stroke, the global sleep apnea patient pool is likely to grow in the years to come. However, dearth of reimbursement/insurance coverage and patient compliance seem to be hindering the growth of this market. In this report, the North American sleep apnea devices market is broadly classified into sleep apnea diagnostic devices and sleep apnea therapeutic devices. On the basis of products, the sleep apnea diagnostic devices market is further divided into home sleep testing/portable monitoring, traditional diagnostic (fixed PSG/in-lab PSG devices), respiratory polygraphs, two channel screening devices, single channel screening devices, and actigraphy systems. Key Topics Covered: 1 Executive Summary 2 Introduction 3 Market Overview 4 North American Sleep Apnea Devices Market, By Segment/Geography 5 Competitive Landscape 6 Company Profiles Companies Mentioned: - Advanced Brain Monitoring - Ambulatory Monitoring - Bmc Medical - Cadwell Laboratories - Carefusion Corporation - Clevemed - Compumedics - Fisher And Paykel Healthcare - Itamar Medical - Natus Medical - Nihon Kohden - Novasom - Philips Healthcare - Resmed - Weinmann Medical Devices Gmbh & Co For more information visit http://www.researchandmarkets.com/research/dn...cro_market
BABY: 36.96 (-0.03)
Sleep Apnea Diagnostic and Therapeutic Devices - 2014 Global Strategic Business Report
M2 - Thu Oct 30, 6:19AM CDT
Research and Markets (http://www.researchandmarkets.com/research/qbnnd7/sleep_apnea) has announced the addition of the "Sleep Apnea Diagnostic and Therapeutic Devices - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa, and Latin America. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 71 companies including many key and niche players such as: - Cadwell Laboratories, Inc. - CareFusion Corporation - Cleveland Medical Devices, Inc. - Compumedics Ltd. - DeVilbiss Healthcare - Global Medical Holdings LLC - Fisher & Paykel Healthcare Limited - GE Healthcare - Itamar Medical Ltd. - Invacare Corporation - Natus Medical Inc. - Embla Systems, Inc. - Grass Technologies - Philips Healthcare - ResMed Inc. - Teleflex Medical - Weinmann Ger?te f?r Medizin GmbH CCo. KG Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Market Overview 2. Market Trends And Dynamics 3. Sleep Apnea - A Synopsis 4. Sleep Apnea Diagnostic And Therapeutic Devices 5. Research Findings In Recent Past 6. Product Launches/Introductions 7. Recent Industry Activity 8. Focus On Select Players 9. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Latin America 7. Middle East And Africa IV. Competitive Landscape Total Companies Profiled: 71 (including Divisions/Subsidiaries - 76) - The United States (48) - Canada (4) - Japan (1) - Europe (12) - - Germany (3) - - The United Kingdom (2) - - Italy (2) - - Spain (2) - - Rest of Europe (3) - Asia-Pacific (Excluding Japan) (
- Middle East (3) For more information visit http://www.researchandmarkets.com/research/qb...leep_apnea
BABY: 36.96 (-0.03), IVC: 17.13 (+0.15), RMD: 66.25 (+0.79)
Respiratory Care Equipment and Supplies - 2014 Global Strategic Business Report
M2 - Tue Oct 28, 4:01AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9qjvss/respiratory_care) has announced the addition of the "Respiratory Care Equipment and Supplies - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. This report analyzes the worldwide markets for Respiratory Care Equipment and Supplies in US$ Thousands by the following Product Segments: - Spirometers - Other Pulmonary Function Testing (PFT) Equipment - Sleep Apnea Diagnostic Devices - Ventilators - Humidifiers - Nebulizers - PAP (positive airway pressure) - Devices - Oxygen Equipment - Manual Resuscitators - Masks - Circuits & Disposables The report profiles 148 companies including many key and niche players such as: - AirSep Corporation - Allied Healthcare Products, Inc. - CareFusion Corporation - Compumedics Limited - Covidien Ltd. - Dr?ger Medical AG & Co. KGaA - DeVilbiss Healthcare - Fisher & Paykel Healthcare Corporation Limited - GE Healthcare - Getinge Group - MAQUET GmbH & Co. KG - Hamilton Medical AG - Invacare Corporation - Itamar Medical Ltd. - nSpire Health, Inc. - Philips Healthcare - ResMed - VORTRAN Medical Technology - Weinmann Ger?te f?r Medizin GmbH CCo. KG Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Respiratory Care Industry Classification 3. Competition In The Respiratory Care Market 4. Market Trends And Growth Drivers By Segment 5. Respiratory Diagnostics Equipment - A Review 6. Respiratory Therapy Equipment - A Review 7. Review Of Select Disease Conditions Requiring Respiratory Care 8. Pap Devices - The Largest Market Segment In Respiratory Care 9. Home Healthcare Market - A Broad Spectrum 10. Ventilators For Respiratory Care 11. Product Introductions/Innovations 12. Recent Industry Activity 13. Focus On Select Global Players 14. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. The Middle East 7. Latin America IV. Competitive Landscape Total Companies Profiled: 148 (including Divisions/Subsidiaries - 174) - The United States (78) - Canada (4) - Japan (9) - Europe (62) - - France (4) - - Germany (24) - - The United Kingdom (9) - - Italy (7) - - Spain (2) - - Rest of Europe (16) - Asia-Pacific (Excluding Japan) (15) - Latin America (1) - Middle East (5) For more information visit http://www.researchandmarkets.com/research/9q...atory_care
IVC: 17.13 (+0.15), COV: 106.71 (-1.36), AHPI: 1.56 (unch)
Galmed Pharmaceuticals and Itamar Medical to Collaborate on Assessing Aramchol's Effect on Endothelial Function
PR Newswire - Mon Sep 29, 8:13AM CDT
Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed"
, a clinical-stage biopharmaceutical company focused on the development and commercialization of a once-daily, oral medication for the treatment of liver diseases and cholesterol gallstones, announced today that it purchased 60 EndoPAT(TM) devices and accessories from Itamar Medical Ltd. (TASE: ITMR) ("Itamar Medical" , a publicly-traded medical device company whose technology has been cleared by the U.S. Food and Drug Administration, or the FDA, for endothelial, or arterial, function assessment, which is a novel risk marker for cardiovascular disease.
GLMD: 6.80 (+0.03)
Itamar Medical Ltd. signs strategic marketing and distribution agreement for its EndoPAT(TM) device with premier medical device maker Nihon Kohden Japan
Business Wire - Mon Jun 23, 6:30AM CDT
--The EndoPAT(TM) device, employed in non-invasive assessment of arterial health, provides indications used to assess the risk of cardiovascular events
MDT: 75.26 (+0.33)
Micro Market Monitor: North American Sleep Apnea Devices
M2 - Thu Dec 18, 6:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/dnzfqg/micro_market) has announced the addition of the "Micro Market Monitor: North American Sleep Apnea Devices" report to their offering. The North American sleep apnea devices market is estimated to grow at a CAGR of 15.9% from 2014 to 2019. In 2013, the U.S. held the largest share in the North American sleep apnea devices market with 92.2%, followed by Canada. This market holds high growth potential in the future due to a number of forces favoring this market. These include the continuously growing base of sleep apnea patients, increasing awareness of sleep apnea and available diagnostic/therapeutic options, emerging popularity of oral appliances, and technological advancement. About 4% of men and 2% of women suffer from obstructive sleep apnea (OSA), globally. Due to rising obesity rates, the association of comorbidities such as drug-resistant hypertension, congestive heart failure, Type 2 diabetes, and stroke, the global sleep apnea patient pool is likely to grow in the years to come. However, dearth of reimbursement/insurance coverage and patient compliance seem to be hindering the growth of this market. In this report, the North American sleep apnea devices market is broadly classified into sleep apnea diagnostic devices and sleep apnea therapeutic devices. On the basis of products, the sleep apnea diagnostic devices market is further divided into home sleep testing/portable monitoring, traditional diagnostic (fixed PSG/in-lab PSG devices), respiratory polygraphs, two channel screening devices, single channel screening devices, and actigraphy systems. Key Topics Covered: 1 Executive Summary 2 Introduction 3 Market Overview 4 North American Sleep Apnea Devices Market, By Segment/Geography 5 Competitive Landscape 6 Company Profiles Companies Mentioned: - Advanced Brain Monitoring - Ambulatory Monitoring - Bmc Medical - Cadwell Laboratories - Carefusion Corporation - Clevemed - Compumedics - Fisher And Paykel Healthcare - Itamar Medical - Natus Medical - Nihon Kohden - Novasom - Philips Healthcare - Resmed - Weinmann Medical Devices Gmbh & Co For more information visit http://www.researchandmarkets.com/research/dn...cro_market
BABY: 36.96 (-0.03)
Sleep Apnea Diagnostic and Therapeutic Devices - 2014 Global Strategic Business Report
M2 - Thu Oct 30, 6:19AM CDT
Research and Markets (http://www.researchandmarkets.com/research/qbnnd7/sleep_apnea) has announced the addition of the "Sleep Apnea Diagnostic and Therapeutic Devices - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa, and Latin America. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 71 companies including many key and niche players such as: - Cadwell Laboratories, Inc. - CareFusion Corporation - Cleveland Medical Devices, Inc. - Compumedics Ltd. - DeVilbiss Healthcare - Global Medical Holdings LLC - Fisher & Paykel Healthcare Limited - GE Healthcare - Itamar Medical Ltd. - Invacare Corporation - Natus Medical Inc. - Embla Systems, Inc. - Grass Technologies - Philips Healthcare - ResMed Inc. - Teleflex Medical - Weinmann Ger?te f?r Medizin GmbH CCo. KG Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Market Overview 2. Market Trends And Dynamics 3. Sleep Apnea - A Synopsis 4. Sleep Apnea Diagnostic And Therapeutic Devices 5. Research Findings In Recent Past 6. Product Launches/Introductions 7. Recent Industry Activity 8. Focus On Select Players 9. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Latin America 7. Middle East And Africa IV. Competitive Landscape Total Companies Profiled: 71 (including Divisions/Subsidiaries - 76) - The United States (48) - Canada (4) - Japan (1) - Europe (12) - - Germany (3) - - The United Kingdom (2) - - Italy (2) - - Spain (2) - - Rest of Europe (3) - Asia-Pacific (Excluding Japan) (
- Middle East (3) For more information visit http://www.researchandmarkets.com/research/qb...leep_apnea BABY: 36.96 (-0.03), IVC: 17.13 (+0.15), RMD: 66.25 (+0.79)
Respiratory Care Equipment and Supplies - 2014 Global Strategic Business Report
M2 - Tue Oct 28, 4:01AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9qjvss/respiratory_care) has announced the addition of the "Respiratory Care Equipment and Supplies - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. This report analyzes the worldwide markets for Respiratory Care Equipment and Supplies in US$ Thousands by the following Product Segments: - Spirometers - Other Pulmonary Function Testing (PFT) Equipment - Sleep Apnea Diagnostic Devices - Ventilators - Humidifiers - Nebulizers - PAP (positive airway pressure) - Devices - Oxygen Equipment - Manual Resuscitators - Masks - Circuits & Disposables The report profiles 148 companies including many key and niche players such as: - AirSep Corporation - Allied Healthcare Products, Inc. - CareFusion Corporation - Compumedics Limited - Covidien Ltd. - Dr?ger Medical AG & Co. KGaA - DeVilbiss Healthcare - Fisher & Paykel Healthcare Corporation Limited - GE Healthcare - Getinge Group - MAQUET GmbH & Co. KG - Hamilton Medical AG - Invacare Corporation - Itamar Medical Ltd. - nSpire Health, Inc. - Philips Healthcare - ResMed - VORTRAN Medical Technology - Weinmann Ger?te f?r Medizin GmbH CCo. KG Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Respiratory Care Industry Classification 3. Competition In The Respiratory Care Market 4. Market Trends And Growth Drivers By Segment 5. Respiratory Diagnostics Equipment - A Review 6. Respiratory Therapy Equipment - A Review 7. Review Of Select Disease Conditions Requiring Respiratory Care 8. Pap Devices - The Largest Market Segment In Respiratory Care 9. Home Healthcare Market - A Broad Spectrum 10. Ventilators For Respiratory Care 11. Product Introductions/Innovations 12. Recent Industry Activity 13. Focus On Select Global Players 14. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. The Middle East 7. Latin America IV. Competitive Landscape Total Companies Profiled: 148 (including Divisions/Subsidiaries - 174) - The United States (78) - Canada (4) - Japan (9) - Europe (62) - - France (4) - - Germany (24) - - The United Kingdom (9) - - Italy (7) - - Spain (2) - - Rest of Europe (16) - Asia-Pacific (Excluding Japan) (15) - Latin America (1) - Middle East (5) For more information visit http://www.researchandmarkets.com/research/9q...atory_care
IVC: 17.13 (+0.15), COV: 106.71 (-1.36), AHPI: 1.56 (unch)
Galmed Pharmaceuticals and Itamar Medical to Collaborate on Assessing Aramchol's Effect on Endothelial Function
PR Newswire - Mon Sep 29, 8:13AM CDT
Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed"
, a clinical-stage biopharmaceutical company focused on the development and commercialization of a once-daily, oral medication for the treatment of liver diseases and cholesterol gallstones, announced today that it purchased 60 EndoPAT(TM) devices and accessories from Itamar Medical Ltd. (TASE: ITMR) ("Itamar Medical" , a publicly-traded medical device company whose technology has been cleared by the U.S. Food and Drug Administration, or the FDA, for endothelial, or arterial, function assessment, which is a novel risk marker for cardiovascular disease. GLMD: 6.80 (+0.03)
Itamar Medical Ltd. signs strategic marketing and distribution agreement for its EndoPAT(TM) device with premier medical device maker Nihon Kohden Japan
Business Wire - Mon Jun 23, 6:30AM CDT
--The EndoPAT(TM) device, employed in non-invasive assessment of arterial health, provides indications used to assess the risk of cardiovascular events
MDT: 75.26 (+0.33)
